Sousan Mohammadi Kebar
, Saeed Hoseininia
* 1 Department of Internal Medicine, Faculty of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran
Abstract
Acute kidney injury (AKI) is a known complication of cancer immunotherapy, which is a type of cancer treatment that uses the body’s immune system to fight cancer cells. The mechanism of acute kidney injury (AKI) in cancer immunotherapy is thought to be related to the immune-mediated inflammation and cytokine release that can occur with immunotherapy. This inflammation can damage the kidney tubules and impair kidney function.
Implication for health policy/practice/research/medical education:
The mechanisms leading to acute kidney injury following cancer immunotherapy are due to the immune-mediated inflammation and injury to the kidneys.
Please cite this paper as: Mohammadi Kebar S, Hoseininia S. Acute kidney injury following cancer immunotherapy; collaboration of oncologists and nephrol. J Nephropharmacol. 2025;14(1):e12696. DOI: 10.34172/npj.2024.12696.